{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:01Z","timestamp":1792783381160,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Peking University International Hospital Internal Grant","award":["YN2024ZD04"],"award-info":[{"award-number":["YN2024ZD04"]}],"id":[{"id":"https:\/\/ror.org\/03jxhcr96","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s11845-026-04350-x","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T02:56:25Z","timestamp":1775703385000},"page":"1997-2005","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adverse events of proton pump inhibitor\u2013associated parathyroid dysfunction: a real-world study based on the FDA adverse event reporting system"],"prefix":"10.1007","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6253-9453","authenticated-orcid":false,"given":"Li","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9218-1720","authenticated-orcid":false,"given":"Ning","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9394-8826","authenticated-orcid":false,"given":"Xue","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"issue":"5","key":"4350_CR1","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s11154-024-09899-5","volume":"25","author":"A Palermo","year":"2024","unstructured":"Palermo A, Tabacco G, Makras P, Zavatta G, Trimboli P, Castellano E et al (2024) Primary hyperparathyroidism: from guidelines to outpatient clinic. Reviews Endocr Metabolic Disorders 25(5):875\u2013896","journal-title":"Reviews Endocr Metabolic Disorders"},{"key":"4350_CR2","doi-asserted-by":"crossref","unstructured":"Zhang L-X, Zhang B, Liu X-Y, Wang Z-M, Qi P, Zhang T-Y et al (2022) Advances in the treatment of secondary and tertiary hyperparathyroidism. Front Endocrinol ; Volume 13\u20132022","DOI":"10.3389\/fendo.2022.1059828"},{"issue":"6","key":"4350_CR3","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41574-024-01075-8","volume":"21","author":"S Khan","year":"2025","unstructured":"Khan S, Khan AA (2025) Hypoparathyroidism: diagnosis, management and emerging therapies. Nat Reviews Endocrinol 21(6):360\u2013374","journal-title":"Nat Reviews Endocrinol"},{"issue":"12","key":"4350_CR4","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1002\/jbmr.4714","volume":"37","author":"JL Pasieka","year":"2022","unstructured":"Pasieka JL, Wentworth K, Yeo CT, Cremers S, Dempster D, Fukumoto S et al (2022) Etiology and Pathophysiology of Hypoparathyroidism: A Narrative Review. J Bone Miner Res 37(12):2586\u20132601","journal-title":"J Bone Miner Res"},{"issue":"1","key":"4350_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40264-014-0259-3","volume":"38","author":"GJ Dal Pan","year":"2015","unstructured":"Dal Pan GJ, Arlett PR (2015) The US Food and Drug Administration-European Medicines Agency collaboration in pharmacovigilance: common objectives and common challenges. Drug Saf 38(1):13\u201315","journal-title":"Drug Saf"},{"key":"4350_CR6","doi-asserted-by":"crossref","unstructured":"Wang L, Li X, Zhao B, Mei D, Jiang J, Duan J (2021) Immune checkpoint inhibitor-associated tumor lysis syndrome: a real-world pharmacovigilance study. Front Pharmacol 12:679207","DOI":"10.3389\/fphar.2021.679207"},{"issue":"11","key":"4350_CR7","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s00198-023-06867-8","volume":"34","author":"D Fitzpatrick","year":"2023","unstructured":"Fitzpatrick D, Lannon R, Laird E, Ward M, Hoey L, Hughes CF et al (2023) The association between proton pump inhibitors and hyperparathyroidism: a potential mechanism for increased fracture\u2014results of a large observational cohort study. Osteoporos Int 34(11):1917\u20131926","journal-title":"Osteoporos Int"},{"issue":"10","key":"4350_CR8","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1111\/jgs.13661","volume":"63","author":"AM Hinson","year":"2015","unstructured":"Hinson AM, Wilkerson BM, Rothman-Fitts I, Riggs AT, Stack BC Jr, Bodenner DL (2015) Hyperparathyroidism Associated with Long-Term Proton Pump Inhibitors Independent of Concurrent Bisphosphonate Therapy in Elderly Adults. J Am Geriatr Soc 63(10):2070\u20132073","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"4350_CR9","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s11695-025-07692-0","volume":"35","author":"K Stevens","year":"2025","unstructured":"Stevens K, Hultin H, Sundbom M, Continuous PPI (2025) Treatment After Gastric Bypass Increases the Risk of Pathological PTH Levels at 10 Years Postoperatively. Obes Surg 35(3):941\u2013945","journal-title":"Obes Surg"},{"issue":"1","key":"4350_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/BF01352010","volume":"53","author":"K Mizunashi","year":"1993","unstructured":"Mizunashi K, Furukawa Y, Katano K, Abe K (1993) Effect of omeprazole, an inhibitor of H+, K+-ATPase, on bone resorption in humans. Calcif Tissue Int 53(1):21\u201325","journal-title":"Calcif Tissue Int"},{"key":"4350_CR11","doi-asserted-by":"crossref","unstructured":"L\u00edvia Marcela dS, Ricardo Ayello G, Marise L-C, Jos\u00e9 Gilberto HV, Evandro de Souza P, Magnus R D-d-S (2016) An approach to the diagnosis and management of a case presenting with recurrent hypomagnesemia secondary to thechronic use of a proton pump inhibitor. Magnes Res 28(4):136\u2013145","DOI":"10.1684\/mrh.2015.0395"},{"issue":"4","key":"4350_CR12","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.metabol.2012.09.011","volume":"62","author":"AI Sharara","year":"2013","unstructured":"Sharara AI, El-Halabi MM, Ghaith OA, Habib RH, Mansour NM, Malli A et al (2013) Proton pump inhibitors have no measurable effect on calcium and bone metabolism in healthy young males: A prospective matched controlled study. Metabolism - Clin Experimental 62(4):518\u2013526","journal-title":"Metabolism - Clin Experimental"},{"issue":"4","key":"4350_CR13","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1053\/j.gastro.2018.11.023","volume":"156","author":"KE Hansen","year":"2019","unstructured":"Hansen KE, Nieves JW, Nudurupati S, Metz DC, Perez MC (2019) Dexlansoprazole and Esomeprazole Do Not Affect Bone Homeostasis in Healthy Postmenopausal Women. Gastroenterology 156(4):926\u2013934e926","journal-title":"Gastroenterology"},{"issue":"9","key":"4350_CR14","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1046\/j.1365-2036.1999.00545.x","volume":"13","author":"W Dammann, Burkhardt","year":"1999","unstructured":"Dammann, Burkhardt W (1999) The effects of oral rabeprazole on endocrine and gastric secretory function in healthy volunteers. Aliment Pharmacol Ther 13(9):1195\u20131203","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"4350_CR15","doi-asserted-by":"publisher","first-page":"bvad013","DOI":"10.1210\/jendso\/bvad013","volume":"7","author":"JL Shaker","year":"2023","unstructured":"Shaker JL, Wermers RA (2023) The Eucalcemic Patient With Elevated Parathyroid Hormone Levels. J Endocr Soc 7(4):bvad013","journal-title":"J Endocr Soc"},{"issue":"2","key":"4350_CR16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1210\/jc.2018-01151","volume":"104","author":"P Piranavan","year":"2019","unstructured":"Piranavan P, Li Y, Brown E, Kemp EH, Trivedi N (2019) Immune Checkpoint Inhibitor-Induced Hypoparathyroidism Associated With Calcium-Sensing Receptor-Activating Autoantibodies. J Clin Endocrinol Metabolism 104(2):550\u2013556","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"6","key":"4350_CR17","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.beem.2018.12.002","volume":"32","author":"F Tecilazich","year":"2018","unstructured":"Tecilazich F, Formenti AM, Frara S, Giubbini R, Giustina A (2018) Treatment of hypoparathyroidism. Best Pract Res Clin Endocrinol Metab 32(6):955\u2013964","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"4350_CR18","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3109\/00365527709181713","volume":"12","author":"L Grimelius","year":"1977","unstructured":"Grimelius L, Johansson H, Lundqvist G, Olazabal A, Polak JH, Pearse AGE (1977) The Parathyroid Glands in Experimentally Induced Hypergastrinemia in the Rat. Scand J Gastroenterol 12(6):739\u2013744","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"4350_CR19","first-page":"165","volume":"27","author":"F Koohpeyma","year":"2024","unstructured":"Koohpeyma F, Taghiyan S, Shams M (2024) Proton-pump inhibitor-induced bone loss is preventable by concomitant use of a long-acting somatostatin analogue. Iran J Basic Med Sci 27(2):165\u2013169","journal-title":"Iran J Basic Med Sci"},{"issue":"9","key":"4350_CR20","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1056\/NEJM198708273170903","volume":"317","author":"S Sheikh Mudassir","year":"1987","unstructured":"Sheikh Mudassir S, Santa Ana Carol A, Nicar Michael J, Schiller Lawrence R, Fordtran John S (1987) Gastrointestinal Absorption of Calcium from Milk and Calcium Salts. N Engl J Med 317(9):532\u2013536","journal-title":"N Engl J Med"},{"key":"4350_CR21","doi-asserted-by":"crossref","unstructured":"Srinutta T, Chewcharat A, Takkavatakarn K, Praditpornsilpa K, Eiam-Ong S, Jaber BL et al (2019) Proton pump inhibitors and hypomagnesemia: A meta-analysis of observational studies. Medicine 98(44):e17788","DOI":"10.1097\/MD.0000000000017788"},{"issue":"4","key":"4350_CR22","doi-asserted-by":"publisher","first-page":"e13846","DOI":"10.1111\/apha.13846","volume":"235","author":"LMM Gommers","year":"2022","unstructured":"Gommers LMM, Hoenderop JGJ, de Baaij JHF (2022) Mechanisms of proton pump inhibitor-induced hypomagnesemia. Acta Physiol 235(4):e13846","journal-title":"Acta Physiol"},{"key":"4350_CR23","doi-asserted-by":"crossref","unstructured":"Ma\u0142gorzata B, Janusz P, Micha\u0142 P (2024) Hypomagnesaemia leading to parathyroid dysfunction, hypocalcaemia, and hypokalaemia as a complication of long-term treatment with a proton pump inhibitor - a literature review. Endokrynol Pol 75(4):359\u2013365","DOI":"10.5603\/ep.98576"},{"key":"4350_CR24","doi-asserted-by":"crossref","unstructured":"Vetter T, Lohse MJ (2002) Magnesium and the parathyroid. Curr Opin Nephrol Hypertens 11(4)403\u2013410","DOI":"10.1097\/00041552-200207000-00006"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-026-04350-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-026-04350-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-026-04350-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:11:46Z","timestamp":1789783906000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-026-04350-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4350"],"URL":"https:\/\/doi.org\/10.1007\/s11845-026-04350-x","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"31 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declared no potential conflicts of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}